Blood in the urine that is only visible under a microscope is known as microscopic hematuria.
In an updated guideline, patients with microscopic hematuria are divided into three risk categories for cancer in the urinary tract.
The most important change in the updated guideline is the move away from an imaging examination, namely, CT urography, in all patients with microscopic hematuria.
This new approach limits the radiation and contrast agent exposure for the patient.
SGLT-2 inhibitors are a class of drugs used to treat type 2 diabetes, the type of diabetes that occurs in adults.
It has been shown that SGLT-2 inhibitors can also help patients without type 2 diabetes.
Three randomized clinical studies have shown that clinical outcomes improve in patients with heart failure, regardless of whether they have diabetes or not in addition to heart failure.
–
